Skip to content

Dosage of Pethidine Hydrochloride during Bronchoscopy and Associated Factors

Dosage of Pethidine Hydrochloride during Bronchoscopy and Associated Factors - Dosage of Pethidine Hydrochloride during Bronchoscopy and Associated Factors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000056057
Enrollment
204
Registered
2024-11-05
Start date
2024-01-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory diseases

Interventions

None listed

Sponsors

Matsuyama Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Between January 2023 and December 2023, 205 patients underwent bronchoscopy using pethidine hydrochloride in the respiratory medicine department of our hospital were included in the study.

Exclusion criteria

Exclusion criteria: One case was excluded due to missing data in the nursing records.

Design outcomes

Primary

MeasureTime frame
pethidine dosage during bronchoscopy.

Countries

Japan

Contacts

Public ContactKotaro Kajiwara

Matsuyama Red Cross Hospital Department of Respiratory Medicine

respiratory24@outlook.jp0899241111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026